Show simple item record

dc.contributor.authorBelot, A.
dc.contributor.authorGourbeyre, O.
dc.contributor.authorHong, C.C.
dc.date.accessioned2020-03-25T14:53:14Z
dc.date.available2020-03-25T14:53:14Z
dc.date.issued2020
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85081633777&doi=10.3324%2fHAEMATOL.2019.236133&partnerID=40&md5=694f26f2b388f9a983b9b2fdfb7f2cd0
dc.identifier.urihttp://hdl.handle.net/10713/12375
dc.description.abstracten_US
dc.description.sponsorshipD.M. was supported by the Cooley’s Anemia Foundation, the French Foundation for Rare Diseases, the Région Midi-Pyrénées and ANR (ANR-17-CE14-0036-01 and ANR-17-CE14-0031-01). H.C. and M.-P.R. were supported in part by grants from FRM (DEQ2000326528) and ANR (ANR-13-BSV3-0015-01). This work was also supported by the “Programme des Investissements d’Avenir” ANINFIMIP (ANR-11EQPX-0003).en_US
dc.description.urihttps://doi.org/10.3324/HAEMATOL.2019.236133en_US
dc.language.isoen_USen_US
dc.publisherFerrata Storti Foundationen_US
dc.relation.ispartofHaematologica
dc.subjectiron-refractory iron-deficiency anemiaen_US
dc.subjectmatriptase-2en_US
dc.subjectkinase inhibitoren_US
dc.subjectLJ000328,en_US
dc.subject.meshSerine Proteasesen_US
dc.subject.meshHepcidinsen_US
dc.titleLJ000328, a novel ALK2/3 kinase inhibitor, represses hepcidin and significantly improves the phenotype of IRIDAen_US
dc.typeArticleen_US
dc.identifier.doi10.3324/HAEMATOL.2019.236133
dc.identifier.pmid31806689


This item appears in the following Collection(s)

Show simple item record